市場調査レポート

米国の軟部組織補強および再生市場

US Market for Soft Tissue Reinforcement and Regeneration 2014 (Forecasted to 2020) - MedSuite

発行 iData Research Inc. 商品コード 315013
出版日 ページ情報 英文 225 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。

ご注意: Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の軟部組織補強および再生市場 US Market for Soft Tissue Reinforcement and Regeneration 2014 (Forecasted to 2020) - MedSuite
出版日: 2014年10月01日 ページ情報: 英文 225 Pages
概要

米国の軟部組織補強および再生市場は、幅広い分野の外科的治療に用いられる特殊なグラフトデバイスで構成されています。従来より合成人工製品が用いられてきましたが、最近では生物学的製品が勢いを増しています。再生能力の優れた新製品の開発によって、治癒プロセスの短縮や術後の合併症の可能性を低減しています。

当レポートは、米国の軟部組織補強および再生市場について調査し、市場の概要とともに、セグメント別の動向、市場発展予測、競合動向などをまとめています。

第1章 エグゼクティブサマリー

第2章 調査方法

第3章 米国の軟部組織補強および再生市場

  • イントロダクション
  • 市場概要
  • セグメント別動向分析
  • 促進因子と阻害因子
  • 競合分析
  • HERFINDAHL指標
  • 合併・買収

第4章 処置

  • 処置全体
  • 乳房再建処置
  • ヘルニア修復処置
  • 硬膜修復処置
  • 膣スリング処置
  • 皮膚修復処置
  • スポーツ医学および腱補強処置
  • 歯科用軟部組織再生処置

第5章 乳房再建市場

  • イントロダクション
  • 市場概要
  • 市場分析および予測
  • 促進因子と阻害因子
  • 競合分析

第6章 ヘルニア修復市場

  • イントロダクション
  • 市場概要
  • 市場分析および予測
  • 促進因子と阻害因子
  • 競合分析

第7章 硬膜修復市場

  • イントロダクション
  • 市場概要
  • 市場分析および予測
  • 促進因子と阻害因子
  • 競合分析

第8章 膣スリング市場

  • イントロダクション
  • 市場概要
  • 市場分析および予測
  • 促進因子と阻害因子
  • 競合分析

第9章 皮膚修復市場

  • イントロダクション
  • 市場概要
  • 市場分析および予測
  • 促進因子と阻害因子
  • 競合分析

第10章 スポーツ医学および腱補強市場

  • イントロダクション
  • 市場概要
  • 市場分析および予測
  • 促進因子と阻害因子
  • 競合分析

第11章 歯科用軟組織再生市場

  • イントロダクション
  • 市場概要
  • 市場分析および予測
  • 促進因子と阻害因子
  • 競合分析

略語解説

目次
Product Code: iDATA_USSTR14_RPT

The U.S. soft tissue reinforcement and regeneration market consists of specialized grafting devices utilized for the surgical treatment of a broad range of indications. While synthetic alloplast products have been traditionally used, newer biologic products have been gaining traction in this market. These new products offer superior regenerative results by expediting the healing process and reducing the likelihood of further post-operative complications.

Biologic products have a significantly higher cost, but in most cases, the added benefits they offer outweigh their premium prices. The increasing unit sales of these specialized biologic products combined with their substantially higher ASP will fuel strong growth in the overall market.

The breast reconstruction market will more than double in value over the forecast period. Exceptionally strong double-digit growth will be driven by increases in unit sales volumes. The breast reconstruction market will more than double in value over the forecast period. Exceptionally strong double-digit growth will be driven by increases in unit sales volumes.

The incidence of breast cancer in younger women has been increasing in the United States; this population is more likely to opt for both mastectomy and breast reconstruction. The vast majority of breast reconstructions were tissue expander/implant-based (TEI) reconstructions. The remaining procedures were performed with autologous tissue, using techniques such as latissimus dorsi myocutaneous (LDM) flap, deep inferior epigastric perforators (DIEP) flap and transverse rectus abdominis myocutaneous (TRAM) flap.

In the last few decades, there has been an ongoing trend in the U.S. for women to undergo a prophylactic double mastectomy for preventative measures, even if breast cancer was only diagnosed in one breast. If the patient then decides to undergo breast reconstruction, both breasts must be completely rebuilt. This has caused the rate of bilateral reconstructions to skyrocket and has dramatically impacted the growth of the breast reconstruction market, as one product is usually used for each breast during a reconstructive procedure.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 U.S. MARKET FOR SOFT TISSUE REINFORCEMENT AND REGENERATION
  • 1.2 BREAST RECONSTRUCTION MARKET
  • 1.3 HERNIA REPAIR MARKET
  • 1.4 DURAL REPAIR MARKET
  • 1.5 VAGINAL SLING MARKET
  • 1.6 SKIN REPAIR MARKET
  • 1.7 SPORTS MEDICINE AND TENDON REINFORCEMENT MARKET
  • 1.8 DENTAL SOFT TISSUE REGENERATION MARKET
  • 1.9 LEADING COMPETITORS

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

U.S. SOFT TISSUE REINFORCEMENT AND REGENERATION MARKET

  • 3.1 INTRODUCTION
  • 3.2 MARKET OVERVIEW
  • 3.3 TREND ANALYSIS BY SEGMENT
  • 3.4 DRIVERS AND LIMITERS
    • 3.4.1 Market Drivers
    • 3.4.2 Market Limiters
  • 3.5 COMPETITIVE ANALYSIS
  • 3.6 HERFINDAHL INDEX
  • 3.7 MERGERS AND ACQUISITIONS

PROCEDURES

  • 4.1 TOTAL PROCEDURES
  • 4.2 BREAST RECONSTRUCTION PROCEDURES
  • 4.3 HERNIA REPAIR PROCEDURES
  • 4.4 DURAL REPAIR PROCEDURES
  • 4.5 VAGINAL SLING PROCEDURES
  • 4.6 SKIN REPAIR PROCEDURES
  • 4.7 SPORTS MEDICINE AND TENDON REINFORCEMENT PROCEDURES
  • 4.8 DENTAL SOFT TISSUE REGENERATION PROCEDURES

BREAST RECONSTRUCTION MARKET

  • 5.1 INTRODUCTION
  • 5.2 MARKET OVERVIEW
  • 5.3 MARKET ANALYSIS AND FORECAST
    • 5.3.1 Total Breast Reconstruction Market
    • 5.3.2 Allograft Market
    • 5.3.3 Xenograft Market
    • 5.3.4 Alloplast Market
  • 5.4 DRIVERS AND LIMITERS
    • 5.4.1 Market Drivers
    • 5.4.2 Market Limiters
  • 5.5 COMPETITIVE ANALYSIS

HERNIA REPAIR MARKET

  • 6.1 INTRODUCTION
  • 6.2 MARKET OVERVIEW
  • 6.3 MARKET ANALYSIS AND FORECAST
    • 6.3.1 Total Ventral Hernia Repair Market
    • 6.3.1.1 Allograft Market
    • 6.3.1.2 Xenograft Market
    • 6.3.1.3 Total Alloplast Market
    • 6.3.1.3.1 Composite Alloplast Market
    • 6.3.1.3.2 Uncoated Alloplast Market
    • 6.3.2 Total Inguinal Hernia Repair Market
    • 6.3.2.1 Allograft Market
    • 6.3.2.2 Xenograft Market
    • 6.3.2.3 Total Alloplast Market
    • 6.3.2.3.1 Composite Alloplast Market
    • 6.3.2.3.2 Uncoated Alloplast Market
  • 6.4 DRIVERS AND LIMITERS
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 COMPETITIVE ANALYSIS

DURAL REPAIR MARKET

  • 7.1 INTRODUCTION
  • 7.2 MARKET OVERVIEW
  • 7.3 MARKET ANALYSIS AND FORECAST
    • 7.3.1 Total Dural Repair Market
    • 7.3.2 Allograft Market
    • 7.3.3 Xenograft Market
    • 7.3.4 Alloplast Market
  • 7.4 DRIVERS AND LIMITERS
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 COMPETITIVE ANALYSIS
    • 7.5.1 Leading Competitors

VAGINAL SLING MARKET

  • 8.1 INTRODUCTION
  • 8.2 MARKET OVERVIEW
  • 8.3 MARKET ANALYSIS AND FORECAST
    • 8.3.1 Total Vaginal Sling Market
    • 8.3.2 Biologic Market
    • 8.3.3 Synthetic Market
  • 8.4 DRIVERS AND LIMITERS
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 COMPETITIVE ANALYSIS
    • 8.5.1 Leading Competitors

SKIN REPAIR MARKET

  • 9.1 INTRODUCTION
  • 9.2 MARKET OVERVIEW
  • 9.3 MARKET ANALYSIS AND FORECAST
    • 9.3.1 Collagen Dressing Market
    • 9.3.2 Skin Substitute Market
  • 9.4 DRIVERS AND LIMITERS
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 COMPETITIVE ANALYSIS
    • 9.5.1 Leading Competitors

SPORTS MEDICINE AND TENDON REINFORCEMENT MARKET

  • 10.1 INTRODUCTION
  • 10.2 MARKET OVERVIEW
  • 10.3 MARKET ANALYSIS AND FORECAST
    • 10.3.1 Total Rotator Cuff Reinforcement Market
    • 10.3.1.1 Allograft Market
    • 10.3.1.2 Xenograft Market
    • 10.3.1.3 Alloplast Market
    • 10.3.2 Total Achilles Tendon Reinforcement Market
    • 10.3.2.1 Allograft Market
    • 10.3.2.2 Xenograft Market
    • 10.3.2.3 Alloplast Market
  • 10.4 DRIVERS AND LIMITERS
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 COMPETITIVE ANALYSIS
    • 10.5.1 Leading Competitors

DENTAL SOFT TISSUE REGENERATION MARKET

  • 11.1 INTRODUCTION
  • 11.2 MARKET OVERVIEW
  • 11.3 MARKET ANALYSIS AND FORECAST
    • 11.3.1 Total Dental Soft Tissue Regeneration Market
    • 11.3.2 Allograft Market
    • 11.3.3 Xenograft Market
  • 11.4 DRIVERS AND LIMITERS
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 COMPETITIVE ANALYSIS
    • 11.5.1 Leading Competitors

ABBREVIATIONS

Back to Top